The mission of the Data Science Shared Resource (DSSR) is to provide professional expertise in biostatistics, bioinformatics and clinical research informatics for all Vanderbilt-Ingram Cancer Center (VICC) investigators. Functions provided by the DSSR include: development of experimental designs, power and sample size analysis; data acquisition and database development; patient identification within the electronic health record (eHR); statistical and bioinformatics analysis and interpretation of findings; collaboration on presentation of results; education in biostatistics and bioinformatics methods; and development of tools/methods with application to laboratory and clinical research. To achieve these functions, the DSSR Director, co-Director, and program leaders are constantly available to VICC investigators. The primary objectives of the DSSR are: 1) to ensure scientific rigor and reproducibility in all VICC studies through key services: experimental design; accurate and reliable data capture; and appropriate, reproducible analysis techniques; 2) to provide study design and power and sample size analysis, as well as to review all laboratory, animal, clinical, omics and prevention studies, including a feasibility assessment that considers both technical feasibility as well as patient population analytics (as appropriate); 3) to collaborate in providing statistical and bioinformatics data analysis, interpretation of results, and the writing of final study reports and manuscripts; 4) to develop and evaluate statistical and bioinformatics methods and software for experimental design, visualization and data analysis; 5) to provide custom database design, data entry, data tracking, forms, queries, and reports, and to maintain electronic data capture (EDC) systems for information storage and retrieval, as well as for study, participant, and/or specimen management, for investigator-initiated clinical trials, other clinical research, or laboratory studies; 6) to work with the Clinical Trials Shared Resource (CTSR) and VICC investigators to develop research project databases, to maintain data quality control and ensure timely data capture; 7) to work with the Genomic Sciences Shared Resource (GSSR) in the development of bioinformatics tools and pipelines, to ensure data quality control and provide novel computational biology support; 8) to train VICC members in research design and data analysis through seminars, workshops and individual sessions; 9) to catalyze research productivity by providing common informatics support including software development, shared research applications and shared research infrastructure; 10) to aid in translating ?genomically-enabled? best practices into clinical decision support; 11) to develop infrastructure, processes and frameworks to aid in identifying patient populations within the electronic health record; 12) to ensure HIPAA compliance in use of patient data by maintaining privacy standards and creating limited or de-identified datasets as appropriate to IRB-approved study aims.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-25
Application #
10024637
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1998-09-01
Project End
2025-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719
Salisbury-Ruf, Christi T; Bertram, Clinton C; Vergeade, Aurelia et al. (2018) Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Elife 7:
Laroumanie, Fanny; Korneva, Arina; Bersi, Matthew R et al. (2018) LNK deficiency promotes acute aortic dissection and rupture. JCI Insight 3:
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Phelps, Hannah M; Al-Jadiry, Mazin F; Corbitt, Natasha M et al. (2018) Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq. World J Pediatr 14:585-593
Liu, Qi; Herring, Charles A; Sheng, Quanhu et al. (2018) Quantitative assessment of cell population diversity in single-cell landscapes. PLoS Biol 16:e2006687
Almodovar, Karinna; Iams, Wade T; Meador, Catherine B et al. (2018) Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse. J Thorac Oncol 13:112-123

Showing the most recent 10 out of 2462 publications